Navigation Links
Idenix to Host Conference Call Discussing Second Quarter 2009 Financial Results
Date:7/14/2009

CAMBRIDGE, Mass., July 14 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc., (Nasdaq: IDIX) announced today that it will report its financial results for the second quarter of 2009 on Monday, July 20, 2009 after U.S. financial markets close.

In conjunction with the issuance of the press release, Idenix management will host a conference call at 4:30 p.m. ET on Monday, July 20, 2009 to discuss the company's financial results for the second quarter of 2009 and provide an update on the company's discovery and development programs.

To access the call please dial 800-774-5358 U.S./Canada or 706-758-9475 International and enter passcode 20088902 or to listen to a live webcast and view accompanying slides, go to "Calendar of Events" in the Idenix Investor Center at www.idenix.com. A replay of the call will also be available from 6:30 p.m. ET on July 20, 2009 until August 3, 2009 12:00 a.m. ET. To access the replay, please dial 800-642-1687 U.S./Canada or 706-645-9291 International and enter passcode 20088902. An archived webcast will also be available for two weeks after the call on the Idenix website.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus. For further information about Idenix, please refer to http://www.idenix.com.

    Amy Sullivan 617-995-9838 (investors)
    Teri Dahlman 617-995-9905 (media)


'/>"/>
SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
2. Idenix to Host Conference Call Discussing Third Quarter 2007 Financial Results
3. Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference
4. Idenix to Host Conference Call Discussing Fourth Quarter 2007 Financial Results
5. Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL)
6. Idenix Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
7. Idenix Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
8. Idenix Pharmaceuticals to Present at the Seventh Annual Needham and Company, LLC Biotechnology and Medical Technology Conference
9. Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results
10. Idenix Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
11. Idenix to Host Conference Call Discussing Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Distinguished Professor of Engineering at the University of ... solve problems in energy engineering, environmental sustainability and ... zeolites, porous rock with a well-defined, crystalline structure. ... so precisely decided that zeolites can separate molecules ... an angstrom (one-tenth of a nanometer), making them ...
(Date:7/24/2014)... , July 24, 2014 SRI International has ... the National Institute of Allergy and Infectious Diseases (NIAID), ... preclinical development of potential therapies for HIV infection and ... treat HIV and AIDS and the complications and opportunistic ... for preventing sexual transmission of HIV. ...
(Date:7/24/2014)... N.J. , July 24, 2014 ... provider of regulatory and ethical review services for ... Alliance Biosciences. Formerly a division of ... was the leading biosafety and biosecurity consulting firm ... With this addition, WCG,s biosafety division – WCG ...
(Date:7/24/2014)... 2014   Cypher Genomics, Inc., the ... Adam Simpson as president and chief ... comprehensive annotation and interpretation of individual human genomes ... "Cypher,s technology has the potential to play a ... accuracy, optimizing therapeutic approaches and reducing adverse drug ...
Breaking Biology Technology:University of Delaware researcher describes new approach for creating organic zeolites 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 3WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 3Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 2Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 3
... ... , ... 2009 -- Surety, LLC , the leading provider of data integrity protection ... Protecting and Legally Defending the Authenticity of Your Scientific Data" on December 9, 2009. ...
... , SANTA CLARA, Calif., Dec. 7 Cell Biosciences, ... Inc. of Lexington, Massachusetts, a leader in sample preparation ... acquisition adds Protein Forest,s novel digital ProteomeChip(TM) product line ... protein analysis. , Protein Forest, founded in 2002, pioneered ...
... , , RESEARCH TRIANGLE PARK, N.C., ... innovative treatments for diseases of the central nervous system, today announced ... that CeNeRx,s novel compound TriRima (TM) reversibly inhibits MAO-A (monoamine ... role in the regulation of mood. TriRima is ...
Cached Biology Technology:Surety Leads Web Symposium to Address Data Integrity Issues in Bio-Sciences Industry 2Cell Biosciences Acquires Protein Forest 2Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 2Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 3Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 4
(Date:7/24/2014)... Calif. -- To reduce fire hazard in the United ... mechanically cutting woody shrubs and suppressed trees (ladder fuels). ... burned during periods of low fire danger in order ... and minimize hazardous air pollutants, managers often cover all ... plastic, commonly referred to as agricultural plastic, in order ...
(Date:7/24/2014)... into the potato genes that best adapt to the ... rainfall and increased extremes of hot and cold temperatures.The ... order to create new potato varieties that will adapt ... to find out how the current potato varieties will ... and lower temperatures. , This research is part of ...
(Date:7/24/2014)... Hundreds of fires covered central Africa in mid-July 2014, ... Multiple red hotspots, which indicate areas of increased temperatures, ... the Democratic Republic of the Congo (northeast), and Zambia ... hotspots, and in some areas, especially in the Democratic ... to the south. , The fire season is an ...
Breaking Biology News(10 mins):Study gives new perspective on agricultural plastic, debris burning, and air quality 2Neiker-Tecnalia is researching the potato genes that best adapt to climate change 2
... 14, 2008) − The accumulation of fat in the liver ... by consuming resveratrol, according to a new study with mice. ... produced in the liver of mice fed alcohol and, at ... the liver is broken down. Chronic alcohol consumption ...
... of worm grunting practiced in the Apalachicola National Forest in ... observation made by Charles Darwin. , Worm grunting involves going ... and then rubbing the top of the stake with a ... a peculiar grunting sound that drives nearby earthworms to the ...
... plant-eating predators to fight a superweed spreading throughout Britain ... a world expert on Japanese knotweed at the University ... of Biology has been researching the invasive weed since ... Hollingsworth and Catherine Pashley. Research in the ...
Cached Biology News:Resveratrol prevents fat accumulation in livers of 'alcoholic' mice 2Florida's 'worm grunters' collect bait worms by inadvertently imitating mole sounds 2Florida's 'worm grunters' collect bait worms by inadvertently imitating mole sounds 3Florida's 'worm grunters' collect bait worms by inadvertently imitating mole sounds 4'Plant-eating predator to fight superweed is not magic bullet' 2
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles...
... Clone/PAD: ZMD.467. Immunogen: Synthetic ... of the human rat mouse dog ... Specific for the human occludin protein. ... cell lysates). Reactivity with rat ...
...
... Biochain's plant total protein ... for rapidly screening tissue specific ... Human placenta total protein is ... an interblot control for comparison ...
Biology Products: